Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival.

Future oncology (London, England) - 1 Oct 2018

Fang Aiping, Zhou Shijie, Su Xiaolan, Liu Chuang, Chen Xiaoxin, Wan Yang, Lei Xiaohong, Xie Linshen, Jia Yiping, Wang Wenzhi, Yang Luo, Song Xuejiao, Yao Yuqin

Abstract excerpt

AIM: To assess the prognostic value of RAMP3 expression in terms of overall survival (OS) and recurrence-free survival (RFS) in hepatocellular carcinoma (HCC) patients. MATERIALS & METHODS: Immunochemistry staining was performed to detect RAMP3 expression. Data in the Cancer Genome Atlas-Liver Hepatocellular Cancer were used for secondary analysis. RESULTS: RAMP3 expression was significantly downregulated in HCC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Liver Neoplasms

Share to Mutation

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 29882679
DOI: 10.2217/fon-2018-0296

Genes

RAMP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival.PMID 29882679Read ↗

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathwaysSemantic proximity Read ↗

Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular CarcinomaSemantic proximity Read ↗

MARCH5 promotes autophagy through interaction with P62 leading to malignant progression of hepatocellular carcinomaSemantic proximity Read ↗

Matrin-3 promotes hepatocellular carcinoma progression by regulating cell cycleSemantic proximity Read ↗

Oncofetal Protein IMP3, a New Cancer BiomarkerSemantic proximity Read ↗

The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis.Semantic proximity Read ↗

CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinomaSemantic proximity Read ↗

Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growthSemantic proximity Read ↗

FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1‐Nrf2 signalingSemantic proximity Read ↗

Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinomaSemantic proximity Read ↗

RNA-Binding Protein IMP3 is a Novel Regulator of MEK1/ERK Signaling Pathway in the Progression of Colorectal Cancer through the Stabilization of MEKK1 mRNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.